Meropenem is a carbapenem antibiotic with a broad spectrum of activity that is administered intravenously and used for severe bacterial infections due to sensitive agents. Meropenem is a common cause of mild transient aminotransferase elevations and can rarely result in clinically apparent, cholestatic liver injury. Meropenem Anhydrous is the anhydrous form of meropenem, a broad-spectrum … [Read more…]
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus causing coronavirus disease 2019 (COVID‑19). Prior to the COVID‑19 pandemic, work to develop a vaccine against coronavirus diseases like severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) established knowledge about the structure and function coronaviruses; this knowledge enabled accelerated development of various vaccine technologies during early … [Read more…]
Estrogen Therapy/Estrogen Therapy (ET)is a form of hormone replacement therapy (HRT), that are a useful in case of deficiency of estrogen therapy that indicates uncomfortable symptoms accompany menopause-related disease conditions.[rx] The Women’s Health Initiative trial has made the use of estrogen therapy obsolete in terms of preventing vasomotor symptoms, osteoporosis, and cardiovascular diseases. Localized estrogen … [Read more…]
Indications of Estrogen or estrogen is a special type of sex hormone that is responsible for a female to the development and regulation of the female reproductive system and secondary sexual characteristics. There are three major endogenous estrogens that have estrogenic hormonal activity: estrone (E1), estradiol (E2), and estriol (E3). Estradiol, an estrane, is the … [Read more…]
Estrogen is a special type of sex hormone that is responsible for a female to the development and regulation of the female reproductive system and secondary sexual characteristics. There are three major endogenous estrogens that have estrogenic hormonal activity: estrone (E1), estradiol (E2), and estriol (E3). Estradiol, an estrane, is the most potent and prevalent. … [Read more…]
Blood Cancer Drugs/This page lists cancer drugs approved by the Food and Drug Administration (FDA) for leukemia. The list includes generic and brand names. This page also lists common drug combinations used in leukemia. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved but are widely used. The … [Read more…]
Drugs For Blood Cancer/This page lists cancer drugs approved by the Food and Drug Administration (FDA) for leukemia. The list includes generic and brand names. This page also lists common drug combinations used in leukemia. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved but are widely used. … [Read more…]
Lipegfilgrastim is a long-acting glycol-pegylated recombinant form of human granulocyte colony-stimulating factor (G-CSF), with hematopoietic activity. Similar to G-CSF, pegfilgrastim binds to and activates specific cell surface receptors, and stimulates neutrophil progenitor proliferation and differentiation. Therefore, this agent may prevent the duration and incidence of chemotherapy-induced neutropenia. Compared to filgrastim, pegfilgrastim has a prolonged plasma … [Read more…]
Dosage of Filgrastim/Filgrastim is a recombinant, non-pegylated human granulocyte colony-stimulating factor (G-CSF) analog. It is marketed as the brand name Neupogen by Amgen (initially approved in 1998) and as Nivestym, a biosimilar agent by Pfizer. Nivestym was approved by the FDA on July 20th, 2018 [rx]. Between 1998 and the present, Neupogen/filgrastim has been approved for various … [Read more…]
Filgrastim Contraindications and Side Effects/Filgrastim is a recombinant, non-pegylated human granulocyte colony-stimulating factor (G-CSF) analog. It is marketed as the brand name Neupogen by Amgen (initially approved in 1998) and as Nivestym, a biosimilar agent by Pfizer. Nivestym was approved by the FDA on July 20th, 2018 [rx]. Between 1998 and the present, Neupogen/filgrastim has been approved … [Read more…]
Indications and Uses of Filgrastim /Filgrastim is a recombinant, non-pegylated human granulocyte colony-stimulating factor (G-CSF) analog. It is marketed as the brand name Neupogen by Amgen (initially approved in 1998) and as Nivestym, a biosimilar agent by Pfizer. Nivestym was approved by the FDA on July 20th, 2018 [rx]. Between 1998 and the present, Neupogen/filgrastim has been … [Read more…]
Filgrastim is a recombinant, non-pegylated human granulocyte colony-stimulating factor (G-CSF) analog. It is marketed as the brand name Neupogen by Amgen (initially approved in 1998) and as Nivestym, a biosimilar agent by Pfizer. Nivestym was approved by the FDA on July 20th, 2018 [rx]. Between 1998 and the present, Neupogen/filgrastim has been approved for various indications [rx]. … [Read more…]